Skip to main content
. 2023 Jan 30;21(2):100. doi: 10.3390/md21020100

Figure 3.

Figure 3

Pharmacophore-directed chemical modifications of gracillin A leading to novel compounds with distinct pharmacodynamic profiles by selective CypA vs. CypD inhibition [126].